Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Common Share

v3.8.0.1
Earnings Per Common Share
3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Earnings Per Common Share
Earnings Per Common Share
The calculation of earnings per common share (EPS) and diluted EPS for the three months ended March 31, 2018 and 2017 is presented below. For more information on the calculation of EPS, see Note 1 – Summary of Significant Accounting Principles to the Consolidated Financial Statements of the Corporation’s 2017 Annual Report on Form 10-K.
 
 
 
 
 
Three Months Ended March 31
(In millions, except per share information)
2018
 
2017
Earnings per common share
 

 
 

Net income
$
6,918

 
$
5,337

Preferred stock dividends
(428
)
 
(502
)
Net income applicable to common shareholders
$
6,490

 
$
4,835

Average common shares issued and outstanding
10,322.4

 
10,099.6

Earnings per common share
$
0.63

 
$
0.48

 
 
 
 
Diluted earnings per common share
 

 
 

Net income applicable to common shareholders
$
6,490

 
$
4,835

Add preferred stock dividends due to assumed conversions (1)

 
75

Net income allocated to common shareholders
$
6,490

 
$
4,910

Average common shares issued and outstanding
10,322.4

 
10,099.6

Dilutive potential common shares (2)
150.3

 
820.1

Total diluted average common shares issued and outstanding
10,472.7

 
10,919.7

Diluted earnings per common share
$
0.62

 
$
0.45

(1) 
Represents the Series T dividends under the “if-converted” method prior to conversion.
(2) 
Includes incremental dilutive shares from RSUs, restricted stock and warrants.
The Corporation previously issued warrants to purchase 700 million shares of the Corporation’s common stock to the holders of the Series T 6% Non-cumulative preferred stock (Series T). In the third quarter of 2017, the Series T holders exercised the warrants and acquired the 700 million shares of the Corporation’s common stock. For the three months ended March 31, 2017, the 700 million average dilutive potential common shares were included in the diluted share count under the “if-converted” method.
For the three months ended March 31, 2018 and 2017, 62 million average dilutive potential common shares associated with the Series L preferred stock were not included in the diluted share count because the result would have been antidilutive under the “if-converted” method. For the three months ended March 31, 2018 and 2017, average options to purchase seven million and 30 million shares of common stock were outstanding but not included in the computation of EPS because the result would have been antidilutive under the treasury stock method. For the three months ended March 31, 2018, average warrants to purchase 264 million shares of common stock were included in the diluted EPS calculation under the treasury stock method compared to 150 million shares of common stock for the three months ended March 31, 2017. For the three months ended March 31, 2017, average warrants to purchase 122 million shares of common stock were outstanding but not included in the computation of EPS because the result would have been antidilutive under the treasury stock method.